Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MA Providers

Dr. David John Kuter, MD, DPhil

(372 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Harvard Medical School

Professional interests include: blood disorders, thrombosis (blood clots), hemostasis, and more.

102 Endicott Street
Danvers, MA 01923

(978) 882-6060

Dr. David John Kuter, MD, DPhil is a medical oncologist in Danvers, MA specializing in medical oncology, adult oncology and adult hematology. He graduated from Harvard Medical School. Dr. David John Kuter, MD, DPhil is affiliated with Massachusetts General Hospital and MASSACHUSETTS GENERAL PHYSICIANS ORGANIZATION INC.

Office Locations

Address:

102 Endicott Street
Danvers, MA 01923

Address:

55 Fruit Street
Boston, MA 02114

Some issues Dr. David John Kuter, MD, DPhil can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Platelet Disorders

Platelet disorders are conditions caused by abnormally low or high levels of platelets in the blood, or by platelets that do not function correctly. Platelets are small blood cells that help stop bleeding by clumping together and forming blood clots, allowing the body to heal.

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:

Thrombocythemia, also referred to as primary or essential thrombosis (ET), develops from irregular bone marrow cells that produce too many platelets. The cause of these bone marrow cells is unknown.
Reactive thrombosis (RT), also referred to as secondary thrombosis, arises from a different condition such as cancer, anemia, spleen removal, or infection. It is most common in older adults, but can occur in people of all ages. Symptoms of reactive thrombosis may gradually develop over time and typically include bruising, gum bleeding, and blood clotting.
Dysfunctional platelets are unable to perform the clotting function in the blood. People with dysfunctional platelets may have normal or low platelet counts. Causes of dysfunctional platelets include autoimmune disorders, hemolysis, infections, blood and bone marrow problems, and liver or kidney conditions.

If a doctor suspects a patient has a platelet disorder, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Platelet disorders can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights. Tests measuring prothrombin time (PT), or how long it takes for blood to clot, can also detect dysfunctional platelets. If platelets do not coagulate within a certain time frame, the patient most likely has dysfunctional platelets.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Patients with high blood count are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with platelet disorders can live healthy and fulfilling lives with proper treatment and precautions.

Thrombocytopenia (Low Platelet Count)

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

In The News

“In lieu of flowers, kindly make Memorial donations in John's name to M.G.H. Hematology Fund, c/o Dr. David Kuter, Yawkey Bldg. #7B, Boston, MA 02114.”—"John Guarnieri", Boston Herald, April 2009

“A larger company-funded study is underway to test AMG 531 in patients with immune thrombocytopenic purpura, which causes the immune system to destroy platelets, said lead investigator David Kuter...”—"Amgen Drug Boosts Blood Cells for Clotting", Los Angeles Times, December 2004

doctor visit	473
hospital care	244
inpatient care	244

**Gender**
Male	172
Female	167

**Ethnicity**
Non-Hispanic White	297
Black	13
Hispanic	12
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	154
From 75 to 84	99
85 and over	36
Less than 65	50

Hypertension	72
High Cholesterol	50
Stroke	10
Ischemic Heart Disease	45
Depression	27
Chronic Kidney Disease	37
Asthma	12
Osteoperosis	13
Atrial Fibrilation	22
Heart Failure	37
Chronic Obstructive Pulmonary Disease	15
Diabetes	28
Dementia	9
Cancer	19

doctor visit	547
hospital care	155
inpatient care	155

**Gender**
Male	146
Female	174

**Ethnicity**
Non-Hispanic White	280
Black	13
Hispanic	0
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	160
From 75 to 84	88
85 and over	30
Less than 65	42

Hypertension	68
High Cholesterol	48
Stroke	12
Ischemic Heart Disease	39
Depression	25
Chronic Kidney Disease	33
Asthma	12
Osteoperosis	15
Atrial Fibrilation	22
Heart Failure	31
Chronic Obstructive Pulmonary Disease	13
Diabetes	26
Dementia	7
Cancer	17

doctor visit	620
hospital care	103
inpatient care	103

**Gender**
Male	338
Female	350

**Ethnicity**
Non-Hispanic White	626
Black	0
Hispanic	24
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	322
From 75 to 84	206
85 and over	74
Less than 65	86

Hypertension	68
High Cholesterol	53
Stroke	9
Ischemic Heart Disease	43
Depression	26
Chronic Kidney Disease	32
Asthma	14
Osteoperosis	15
Atrial Fibrilation	19
Heart Failure	28
Chronic Obstructive Pulmonary Disease	12
Diabetes	26
Dementia	6
Cancer	17

doctor visit	614
hospital care	115
inpatient care	115

**Gender**
Male	176
Female	173

**Ethnicity**
Non-Hispanic White	300
Black	13
Hispanic	0
Asian	0
Other	18
Native American	0

**Age**
From 65 to 74	165
From 75 to 84	104
85 and over	39
Less than 65	41

Hypertension	74
High Cholesterol	52
Stroke	7
Ischemic Heart Disease	42
Depression	28
Chronic Kidney Disease	40
Asthma	18
Osteoperosis	15
Atrial Fibrilation	19
Heart Failure	27
Chronic Obstructive Pulmonary Disease	15
Diabetes	28
Dementia	11
Cancer	16

doctor visit	596
hospital care	84
inpatient care	84

**Gender**
Male	175
Female	180

**Ethnicity**
Non-Hispanic White	315
Black	0
Hispanic	0
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	167
From 75 to 84	107
85 and over	29
Less than 65	52

Hypertension	62
High Cholesterol	43
Stroke	7
Ischemic Heart Disease	43
Depression	32
Chronic Kidney Disease	36
Asthma	10
Osteoperosis	14
Atrial Fibrilation	19
Heart Failure	26
Chronic Obstructive Pulmonary Disease	15
Diabetes	25
Dementia	11
Cancer	13

doctor visit	672
hospital care	107
inpatient care	107

**Gender**
Male	204
Female	202

**Ethnicity**
Non-Hispanic White	363
Black	0
Hispanic	11
Asian	0
Other	17
Native American	0

**Age**
From 65 to 74	195
From 75 to 84	129
85 and over	26
Less than 65	56

Hypertension	65
High Cholesterol	52
Stroke	10
Ischemic Heart Disease	42
Depression	31
Chronic Kidney Disease	41
Asthma	13
Osteoperosis	17
Atrial Fibrilation	17
Heart Failure	23
Chronic Obstructive Pulmonary Disease	13
Diabetes	23
Dementia	11
Cancer	15

doctor visit	632
hospital care	101
inpatient care	101

**Gender**
Male	202
Female	192

**Ethnicity**
Non-Hispanic White	349
Black	0
Hispanic	11
Asian	0
Other	20
Native American	0

**Age**
From 65 to 74	194
From 75 to 84	133
85 and over	19
Less than 65	48

Hypertension	62
High Cholesterol	48
Stroke	8
Ischemic Heart Disease	40
Depression	32
Chronic Kidney Disease	36
Asthma	9
Osteoperosis	16
Atrial Fibrilation	18
Heart Failure	22
Chronic Obstructive Pulmonary Disease	13
Diabetes	22
Dementia	11
Cancer	15

doctor visit	402
hospital care	72
inpatient care	72

**Gender**
Male	196
Female	193

**Ethnicity**
Non-Hispanic White	342
Black	13
Hispanic	0
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	182
From 75 to 84	146
85 and over	17
Less than 65	44

Hypertension	61
High Cholesterol	48
Stroke	8
Ischemic Heart Disease	40
Depression	31
Chronic Kidney Disease	37
Asthma	10
Osteoperosis	14
Atrial Fibrilation	13
Heart Failure	19
Chronic Obstructive Pulmonary Disease	9
Diabetes	23
Dementia	11
Cancer	15

doctor visit	1324
hospital care	71
inpatient care	71

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. David John Kuter, MD, DPhil for Medicare patients.

The highest averages for the top procedures that Dr. David John Kuter, MD, DPhil treated as a medical oncologist in Danvers, MA were hospital care and inpatient care.

doctor visit	653
hospital care	116
inpatient care	116

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. David John Kuter, MD, DPhil.

**Gender**
Female	163
Male	160

**Ethnicity**
Black / African American	5
Asian / Pacific Islander	0
Non-Hispanic White	287
Native American / Alaskan Native	0
Hispanic	5
Other	9

**Age**
85 and over	27
75 to 84	101
Less than 65	41
65 to 74	153

Average of Total of Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. David John Kuter, MD, DPhil treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.

Hypertension	53
High Cholesterol	39
Stroke	7
Ischemic Heart Disease	33
Depression	23
Chronic Kidney Disease	29
Asthma	9
Osteoporosis	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	10
Diabetes	20
Atrial Fibrillation	14
Cancer	12
Dementia	7

Education & Training

Dr. David John Kuter, MD, DPhil graduated from Harvard Medical School. He is certified by the Medical Oncology, American Board of Internal Medicine and has a state license in Massachusetts.

Medical School: Harvard Medical School

Board Certification: Medical Oncology, American Board of Internal Medicine

Licensed In: Massachusetts

Affiliations & Hospitals

Dr. David John Kuter, MD, DPhil is associated with these hospitals and organizations:

Massachusetts General Hospital

MASSACHUSETTS GENERAL PHYSICIANS ORGANIZATION INC

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. David John Kuter, MD, DPhil appears to accept the following insurance providers: Harvard Pilgrim Health Care, MultiPlan, United Healthcare, Tufts Health Plan, Aetna, TRICARE, Medicare, Medicaid, Humana, Railroad Medicare, Coventry, Cigna, Blue California, Beech Street, WellPoint, Medicare ACO, WellSense, Senior Whole Health, Fallon Health, Commonwealth Care Alliance, Blue Cross Blue Shield Medicare, Maine Community Health Options, Mass General Brigham Health Plan, MassHealth and WellSense NH.

Insurance Accepted by Provider includes:

According to our sources, Dr. David John Kuter, MD, DPhil accepts the following insurance providers:

Harvard Pilgrim Health Care

MultiPlan

United Healthcare

Tufts Health Plan

Aetna

TRICARE

Medicare

Medicaid

Humana

Railroad Medicare

Coventry

Cigna

Blue California

Beech Street

WellPoint

Medicare ACO

WellSense

Senior Whole Health

Fallon Health

Commonwealth Care Alliance

Blue Cross Blue Shield Medicare

Maine Community Health Options

Mass General Brigham Health Plan

MassHealth

WellSense NH

Show More

Ratings & Reviews

Dr. David John Kuter, MD, DPhil has an exceptional overall rating with an average of 5.0 out of 5 stars based on 372 ratings. We collect ratings and reviews of Dr. David John Kuter, MD, DPhil from all over the web to help you find the right in Danvers, MA.

Overall Rating

(372 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. David John Kuter, MD, DPhil. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Amgen Inc.	$332,669 Nplate $306,942	Blincyto $10,465	Neulasta $2,400	Aranesp $1,016	$11,847
GENZYME CORPORATION	$66,383 CERDELGA $18,505	ENJAYMO $3,431	NO PRODUCT DISCUSSED $2,172	$42,275
Novartis Pharmaceuticals Corporation	$56,761 PROMACTA $20,049	Fabhalta $2,516	$34,196
Swedish Orphan Biovitrum AB	$54,588 DOPTELET $40,209	$14,379
Shire North American Group Inc	$51,366 VPRIV $14,136	$37,230
Other	$238,081 DOPTELET $31,470	PROMACTA $17,678	ELELYSO $16,662	ZAVESCA MIGLUSTAT $11,415	NO PRODUCT DISCUSSED $9,542	Other $151,313

**Types of Payments**
Consulting Fee	$504,157
Travel and Lodging	$198,243
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$87,631
Food and Beverage	$8,215
Honoraria	$1,500
Other	$102

Research Payments

Dr. David John Kuter, MD, DPhil has received 284 research payments totaling $1,600,287.

Biography

Dr. David Kuter's specialties are adult hematology, adult oncology, and medical oncology. He practices in Boston, MA and Danvers, MA. Areas of expertise for Dr. Kuter include chronic myeloid leukemia (CML), anticoagulants (blood thinners), and anemia. He is rated 5.0 stars (out of 5) by his patients. Dr. Kuter usually honors Blue California, Coventry, and Viant, in addition to other insurance carriers. He graduated from Harvard Medical School. Dr. Kuter is professionally affiliated with Massachusetts General Hospital.

Select Year:

Dr. David John Kuter, MD, DPhil

Office Locations

Some issues Dr. David John Kuter, MD, DPhil can help you with:

In The News

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2013 - 2021

Average Medicare Patient Data From 2013 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. David John Kuter, MD, DPhil From 2013 - 2021

Education & Training

Affiliations & Hospitals

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

Other Providers in Danvers, MA